Salipante, Stephen J |
University Of Washington
United States |
Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation |
1R33CA302385-01 |
|
Nick Hodges, Ph.D. |
Salkowski, Lonie |
University Of Wisconsin-Madison
United States |
Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection |
5R37CA262110-04 |
|
Guillermo Marquez, Ph.D. |
Salman, Emad |
Florida Assn Of Pediatric Tumor Prog
United States |
The Florida Pediatric NCORP: NCI Community Oncology Research Program. |
3UG1CA189973-11S1 |
|
Vanessa A. White, M.P.H. |
Salvemini, Daniela |
Saint Louis University
United States |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
5R01CA261979-04 |
|
Rachel Altshuler, Ph.D. |
Sanchez, Eduardo Vilar |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome |
5R01CA260761-04 |
|
Asad Umar, D.V.M., Ph.D. |
Sanchez, Eduardo Vilar |
University Of Tx Md Anderson Can Ctr
United States |
Cancer Immune-Interception for Lynch Syndrome |
5R01CA257375-05 |
|
Asad Umar, D.V.M., Ph.D. |
Sanchez, Eduardo Vilar |
University Of Tx Md Anderson Can Ctr
United States |
iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium |
2UG1CA242609-07 |
|
Donald Johnsey |
Sanda, Martin G |
Emory University
United States |
Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern |
5U01CA113913-18 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
Sands, Stephen Alan |
Sloan-Kettering Inst Can Research
United States |
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) |
5R01CA283045-02 |
PAR-21-329 (R01 Clinical Trial Optional) |
Marjorie Perloff, M.D. |
Santomasso, Bianca Denise |
Sloan-Kettering Inst Can Research
United States |
Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy |
5R01CA293922-02 |
|
Monica Epstein, B.S.N., RN, OCN |